Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Int. J. Mol. Sci. 2013, 14(6), 11963-11980; doi:10.3390/ijms140611963
Review

In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)

 and *
Received: 19 March 2013; in revised form: 17 May 2013 / Accepted: 22 May 2013 / Published: 5 June 2013
(This article belongs to the Special Issue Non-Alcoholic Fatty Liver Disease Research)
View Full-Text   |   Download PDF [1367 KB, uploaded 19 June 2014]
Abstract: By now, non-alcoholic fatty liver disease (NAFLD) is considered to be among the most common liver diseases world-wide. NAFLD encompasses a broad spectrum of pathological conditions ranging from simple steatosis to steatohepatitis, fibrosis and finally even cirrhosis; however, only a minority of patients progress to end-stages of the disease, and the course of the disease progression to the later stages seems to be slow, developing progressively over several years. Key risk factors including overweight, insulin resistance, a sedentary life-style and an altered dietary pattern, as well as genetic factors and disturbances of the intestinal barrier function have been identified in recent years. Despite intense research efforts that lead to the identification of these risk factors, knowledge about disease initiation and molecular mechanisms involved in progression is still limited. This review summarizes diet-induced and genetic animal models, as well as cell culture models commonly used in recent years to add to the understanding of the mechanisms involved in NAFLD, also referring to their advantages and disadvantages.
Keywords: animal models; in vitro models; non-alcoholic fatty liver disease; insulin resistance; diet animal models; in vitro models; non-alcoholic fatty liver disease; insulin resistance; diet
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Kanuri, G.; Bergheim, I. In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD). Int. J. Mol. Sci. 2013, 14, 11963-11980.

AMA Style

Kanuri G, Bergheim I. In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD). International Journal of Molecular Sciences. 2013; 14(6):11963-11980.

Chicago/Turabian Style

Kanuri, Giridhar; Bergheim, Ina. 2013. "In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)." Int. J. Mol. Sci. 14, no. 6: 11963-11980.



Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert